Literature DB >> 17442941

Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor.

Kabsun Kim1, Junwon Lee, Jung Ha Kim, Hye Mi Jin, Bin Zhou, Soo Young Lee, Nacksung Kim.   

Abstract

Protein inhibitor of activated STAT3 (PIAS3) has been shown to regulate the activity of various transcription factors. In this study, we show that the overexpression of PIAS3 in bone marrow-derived monocyte/macrophage lineage cells attenuates osteoclast formation and down-regulates the expression of NFATc1 and osteoclast-associated receptor (OSCAR), which are important modulators in osteoclastogenesis. PIAS3 has been shown to associate with histone deacetylase 1 as well as with transcription factors, including the microphthalmia transcription factor, NFATc1, and c-Fos. Moreover, overexpression of PIAS3 inhibits the transactivation of target genes such as NFATc1 and OSCAR. This inhibitory effect of PIAS3 is possibly mediated by histone deacetylase 1 recruitment to the promoter regions of NFATc1 and OSCAR. Furthermore, silencing of PIAS3 by RNA interference in osteoclast precursors enhances osteoclast formation as well as gene expression of NFATc1 and OSCAR. Taken together, our results reveal that PIAS3 acts as a modulator in osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442941     DOI: 10.4049/jimmunol.178.9.5588

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Interleukin-6 in bone metastasis and cancer progression.

Authors:  Tasnim Ara; Yves A Declerck
Journal:  Eur J Cancer       Date:  2010-03-23       Impact factor: 9.162

2.  Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation.

Authors:  Taesoo Kim; Kabsun Kim; Seoung Hoon Lee; Hong-Seob So; Junwon Lee; Nacksung Kim; Yongwon Choi
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

3.  HDAC3 and HDAC7 have opposite effects on osteoclast differentiation.

Authors:  Lan Pham; Bria Kaiser; Amanda Romsa; Toni Schwarz; Raj Gopalakrishnan; Eric D Jensen; Kim C Mansky
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

4.  STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.

Authors:  Yiling Yang; Mi Ri Chung; Siru Zhou; Xinyi Gong; Hongyuan Xu; Yueyang Hong; Anting Jin; Xiangru Huang; Weiguo Zou; Qinggang Dai; Lingyong Jiang
Journal:  J Biol Chem       Date:  2019-08-28       Impact factor: 5.157

5.  Transcriptional activity of erythroid Kruppel-like factor (EKLF/KLF1) modulated by PIAS3 (protein inhibitor of activated STAT3).

Authors:  Miroslawa Siatecka; Shefali Soni; Antanas Planutis; James J Bieker
Journal:  J Biol Chem       Date:  2015-02-24       Impact factor: 5.157

6.  PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.

Authors:  Tomohiro Hikata; Hironari Takaishi; Jiro Takito; Akihiro Hakozaki; Mitsuru Furukawa; Shinichi Uchikawa; Tokuhiro Kimura; Yasunori Okada; Masahito Matsumoto; Akihiko Yoshimura; Riko Nishimura; Sakamuri V Reddy; Hiroshi Asahara; Yoshiaki Toyama
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

7.  Platelet-derived growth factor BB enhances osteoclast formation and osteoclast precursor cell chemotaxis.

Authors:  Dian-Qi Li; Qi-Long Wan; Janak L Pathak; Zu-Bing Li
Journal:  J Bone Miner Metab       Date:  2016-09-14       Impact factor: 2.626

8.  Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D.

Authors:  Sandra Baumgart; Nai-Ming Chen; Jens T Siveke; Alexander König; Jin-San Zhang; Shiv K Singh; Elmar Wolf; Marek Bartkuhn; Irene Esposito; Elisabeth Heßmann; Johanna Reinecke; Julius Nikorowitsch; Marius Brunner; Garima Singh; Martin E Fernandez-Zapico; Thomas Smyrk; William R Bamlet; Martin Eilers; Albrecht Neesse; Thomas M Gress; Daniel D Billadeau; David Tuveson; Raul Urrutia; Volker Ellenrieder
Journal:  Cancer Discov       Date:  2014-04-02       Impact factor: 39.397

Review 9.  Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis.

Authors:  Tobias Braun; Jochen Zwerina
Journal:  Arthritis Res Ther       Date:  2011-07-28       Impact factor: 5.156

Review 10.  Regulation of NFATc1 in Osteoclast Differentiation.

Authors:  Jung Ha Kim; Nacksung Kim
Journal:  J Bone Metab       Date:  2014-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.